Clinical and microbiological rationale for the prophylaxis of obstetric and perinatal pathology caused by group B streptococci

Cover Page

Abstract


Background. Bacteriuria caused by group B streptococci (GBS) is a major risk factor for neonatal GBS associated pathology and a risk factor for pregnancy complications such as preterm birth and preterm rupture of membranes.

Objective. Clinical and microbiological rationale for the prophylaxis of obstetrical and perinatal pathology associated with group B streptococci. Methods. A total of 496 pregnant women who made their first prenatal visit within first 12 weeks of gestation were invited to participate. As clinical samples, mid-stream urine, vaginal swabs, rectal swabs from women and inguinal swabs, urine, meconium from newborn infants were used. GBS detection was performed using culture and PCR.

Results. The frequency of GBS detection was 16.3%. GBS associated bacteriuria was detected in 9.8% of the women. The women having GBS in urine at the beginning of pregnancy were significantly more often colonized with the microorganism late in pregnancy in comparison with the women with GBS-colonization of the vagina and/or rectum. Microbiological efficiency of antibiotic therapy of GBS associated bacteriuria using amoxicillin/clavulanic acid exceeded 70%. Clinical efficiency of the therapy consisted in the reduction of preterm birth and preterm rupture of membranes by 25% and 40%, respectively.

Conclusions. Antibiotic therapy of GBS associated bacteriuria results in a decrease of pregnancy complication, which necessitate its use. GBS-colonization of the vagina and rectum in pregnant women is transitory therefore antenatal screening for GBS aimed to prevent neonatal GBS-infection should be performed late in pregnancy or before delivery.


Vladislav O. Khvan

St. Petersburg State Maternity Hospital No 18

Author for correspondence.
Email: vladvit2001@inbox.ru

Russian Federation, Saint Petersburg

Obstetrician-Gynecologist

Elena V. Shipitsyna

Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: iagmail@ott.ru

Russian Federation, Saint Petersburg

PhD, Leading Researcher of Laboratory of Microbiology

Svetlana L. Zatsiorskaya

Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: zatziorskaya@yandex.ru

Russian Federation, Saint Petersburg

PhD, Senior Researcher of Laboratory of Microbiology

Galina V. Grinenko

St. Petersburg State Maternity Hospital No 18

Email: ggrinenko@mail.ru

Russian Federation, Saint Petersburg

PhD, Head Physician

Kira V. Shalepo

Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: iagmail@ott.ru

Russian Federation, Saint Petersburg

PhD, Senior Researcher of Laboratory of Microbiology

Alevtina M. Savicheva

Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: savitcheva@mail.ru

Russian Federation, Saint Petersburg

MD, PhD, Professor, Head of Laboratory of Microbiology

  • Тотолян А.А., Суворов А.Н., Дмитриев А.В. Стрептококки группы В в патологии человека. — СПб.: Человек, 2009. [Totolyan AA, Suvorov AN, Dmitriev AV. Group B streptococci in human pathology. Saint Petersburg: Chelovek; 2009. (In Russ.)]
  • Baker CJ. The spectrum of perinatal group B streptococcal disease. Vaccine. 2013;31(Suppl 4):D3-6. doi: 10.1016/j.vaccine.2013.02.030.
  • Phares CR, Lynfield R, Farley MM, et al.; Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299(17):2056-2065. doi: 10.1001/jama.299.17.2056.
  • Schuchat A. Group B streptococcus. Lancet. 1999;353:51-56. doi: 10.1016/S0140-6736(98)07128-1.
  • Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342(1):15-20. doi: 10.1056/NEJM200001063420103.
  • Оганян К.А., Суворов А.Н., Зациорская С.Л., и др. Течение и исход беременности при колонизации урогенитального тракта женщин стрептококками группы В, содержащими гены SspB семейства // Журнал акушерства и женских болезней. — 2006. — № 2. — С. 47–52. [Oganyan KA, Suvorov AN, Zatsiorskaya SL, et al. The course and outcomes of pregnancy in women with urogenital tract colonization with group B Streptococcus containing genes of SspB family. Journal of Obstetrics and Women’s Diseases. 2006;(2):47-52. (In Russ.)]
  • Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: Revised Guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
  • Money D, Allen VM. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can. 2013;35(10):939-951. doi: 10.1016/S1701-2163(15)30818-5.
  • Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643-654. doi: 10.1086/427507.
  • Pérez-Moreno MO, Picó-Plana E, Grande-Armas J, et al. Group B streptococcal bacteriuria during pregnancy as a risk factor for maternal intrapartum colonization: a prospective cohort study. J Med Microbiol. 2017;66(4):454-460. doi: 10.1099/jmm.0.000465.
  • Kessous R, Weintraub AY, Sergienko R, et al. Bacteruria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes? J Matern Fetal Neonatal Med. 2012;25(10):1983-6. doi: 10.3109/14767058.2012.671872.
  • Donders G, Bellen G, Rezeberga D. Aerobic vaginitis in pregnancy. BJOG. 2011;118(10):1163-70. doi: 10.1111/j.1471-0528.2011.03020.x.
  • Gondo F, da Silva MG, Polettini J, et al. Vaginal flora alterations and clinical symptoms in low-risk pregnant women. Gynecol Obstet Invest. 2011;71(3):158-162. doi: 10.1159/000316051.
  • Zodzika J, Rezeberga D, Jermakova I, et al. Factors related to elevated vaginal pH in the first trimester of pregnancy. Acta Obstet Gynecol Scand. 2011;90(1):41-6. doi: 10.1111/j.1600-0412.2010.01011.x.
  • Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 2009;116(10):1315-24. doi: 10.1111/j.1471-0528.2009.02237.x.
  • Hitti J, Hillier SL, Agnew KJ, et al. Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol. 2001;97:211-9.
  • Rizzo G, Capponi A, Rinaldo D, et al. Interleukin-6 concentrations in cervical secretions identify microbial invasion of the amniotic cavity in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 1996;1:812-7. doi: 10.1016/S0002-9378(96)80004-4.

Supplementary files

Supplementary Files Action
1. Fig. 1. Colonization of pregnant women with group B streptococci and pregnancy outcomes (GBS — group B streptococci, PROM — preterm rupture of membranes) View (84KB) Indexing metadata
2. Fig. 2. Microbiological efficiency of the therapy of GBS associated bacteriuria with amoxicillin/clavulanic acid View (22KB) Indexing metadata
3. Fig. 3. Frequency of persistence of group B streptococci in different clinical samples View (30KB) Indexing metadata

Views

Abstract - 147

PDF (Russian) - 98

PlumX


Copyright (c) 2018 Khvan V.O., Shipitsyna E.V., Zatsiorskaya S.L., Grinenko G.V., Shalepo K.V., Savicheva A.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.